Veradermics MANE
NYSE MANE
$117.11 -4.12 (-3.40%)
As of: Oct 1, 2026 · 3:59 PM EDT

Veradermics (MANE) Change in Cash (2025 - 2026)

Updated

Veradermics' Change in Cash was $150.92 million in Q2 2026, compared with -$23.84 million a year earlier and up 2.9% from the prior quarter.

Analysis

Veradermics (MANE) Change in Cash (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Veradermics' Change in Cash was $253.08 million through Jun 30, 2026; for FY2025, it came in at -$31.32 million.

  • In earlier years, Change in Cash was $36.79 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -1.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -2.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.49 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 739.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.64 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -4.45 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -727.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 649.20 Mn
10 Veradermics 5.07 Bn 5.07 Bn - 150.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 150.92 Mn
Mar 31, 2026 146.65 Mn
Jun 30, 2025 -23.84 Mn
Mar 31, 2025 -20.64 Mn
API Access

Veradermics Change in Cash API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-cash&ticker=MANE&period=max&api_key=YOUR_API_KEY